Filed: 8/13/2024ACC: 0001104659-24-088833
📋 What this filing means
CATALYS PACIFIC, LLC filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $132.49M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$132.49M
Total AUM (reported)
11.13M
Total Shares
Allocation by class
COM$132.49M100.0%
Portfolio Concentration
Top 3$132.49M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 11.13M
Sole
Full voting authority
11.13M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
Mineralys Therapeutics, Inc.
SOLEShares9.19M
TypeSH
Market value$107.58M
81.19%
Sole
9.19M
Shared
0.00
None
0.00
HilleVax, Inc.
SOLEShares1.21M
TypeSH
Market value$17.48M
13.19%
Sole
1.21M
Shared
0.00
None
0.00
Phathom Pharmaceuticals, Inc.
SOLEShares721.96K
TypeSH
Market value$7.44M
5.61%
Sole
721.96K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Mineralys Therapeutics, Inc.SOLE | COM | 9.19M | SH | $107.58M 81.19% | 9.19M | 0.00 | 0.00 |
HilleVax, Inc.SOLE | COM | 1.21M | SH | $17.48M 13.19% | 1.21M | 0.00 | 0.00 |
Phathom Pharmaceuticals, Inc.SOLE | COM | 721.96K | SH | $7.44M 5.61% | 721.96K | 0.00 | 0.00 |